Enhancing CAR-T Cell Therapy Against Solid Tumor by Drug-Free Triboelectric Immunotherapy

Haimei Li; Zichen Wang; Yulin Hu; Guangqin He; Liang Huang; Yi Liu; Zhong Lin Wang; Peng Jiang

doi:10.1016/j.biomaterials.2024.122871

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Corrigendum2024

Corrigendum to ‘Enhancing CAR-T cell therapy against solid tumor by drug-free triboelectric immunotherapy’ [Biomaterials 314 (2025) 122871]

Haimei Li, Zichen Wang, Yulin Hu, Guangqin He, Liang Huang, Yi Liu, Zhong Lin Wang, Peng Jiang

Article2025

On-target off-tumor toxicity from HER2-targeting chimeric antigen receptor (CAR) engineered T cell therapy: current solutions

Zhong Lin Wang

Article2017

Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma

Manuel Fankhauser, Maria A.S. Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W. Lund, Elodie Da Costa, Sylvie Hauert, Marcela Rincón-Restrepo, Christopher Tremblay, Elena M. Cabello, Krisztián Homicskó, Olivier Michielin, Douglas Hanahan, Daniel E. Speiser, Melody A. Swartz

Article2021

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead

Tahereh Soltantoyeh, Behnia Akbari, Amirali Karimi, Ghanbar Mahmoodi Chalbatani, Navid Ghahri-Saremi, Jamshid Hadjati, Michael R Hamblin, Hamid Reza Mirzaei

Chapter in a book2014

Adoptive T-Cell Therapy: Optimizing Chemokine Receptor-Mediated Homing of T Cells in Cancer Immunotherapy

Imran Siddiqui, Alberto Mantovani, Paola Allavena